Norfloxacin antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Norfloxacin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-53-1 | 1. BSA-Norfloxacin 2. Anti-Norfloxacin mouse monoclonal antibody | $2709.00 |
GMP-SMT-53-2 | 1. OVA-Norfloxacin 2. Anti-Norfloxacin mouse monoclonal antibody | $2709.00 |
GMP-SMT-53-3 | 1. BSA-Norfloxacin 2. Anti-Norfloxacin human monoclonal antibody | $2709.00 |
GMP-SMT-53-4 | 1. OVA-Norfloxacin 2. Anti-Norfloxacin human monoclonal antibody | $2709.00 |
GMP-SMT-53-Ag-1 | BSA-Norfloxacin | $756.00 |
GMP-SMT-53-Ag-2 | OVA-Norfloxacin | $756.00 |
GMP-SMT-53-Ab-1 | Anti-Norfloxacin mouse monoclonal antibody | $1953.00 |
GMP-SMT-53-Ab-2 | Anti-Norfloxacin human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Norfloxacin
Cat No. | GMP-SMT-53-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Norfloxacin with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Norfloxacin had been validated with our anti-Hapten antibody Anti-Norfloxacin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Norfloxacin
Cat No. | GMP-SMT-53-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Norfloxacin with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Norfloxacin had been validated with our anti-Hapten antibody Anti-Norfloxacin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Norfloxacin mouse monoclonal antibody
Cat No. | GMP-SMT-53-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.3-0.5 |
Products description | The anti-Hapten antibody against hapten Norfloxacin had been validated with our hapten hapten-carrier conjugates BSA-Norfloxacin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Norfloxacin human monoclonal antibody
Cat No. | GMP-SMT-53-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.3-0.5 |
Products description | The anti-Hapten antibody against hapten Norfloxacin had been validated with our hapten hapten-carrier conjugates BSA-Norfloxacin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
What is Norfloxacin and its Role in Veterinary Drug Residues and Additives?
Norfloxacin is a synthetic, second-generation fluoroquinolone antibiotic with a broad-spectrum antibacterial activity. It is widely employed in veterinary medicine to combat bacterial infections in animals. Norfloxacin functions by inhibiting bacterial DNA gyrase and topoisomerase IV, essential enzymes in bacterial DNA replication. This inhibition effectively halts bacterial growth and proliferation. Its versatility in targeting both Gram-positive and Gram-negative bacteria has made Norfloxacin a valuable tool in veterinary healthcare.
In the context of veterinary drug residues and additives, Norfloxacin's application is pivotal and requires careful consideration. One concern is its potential to accumulate in animal tissues, leading to the presence of Norfloxacin residues in animal-derived products such as meat, milk, and eggs. These residues pose a significant concern from a food safety and public health perspective, as excessive levels can have adverse effects on consumers.
To address this challenge, our biopharmaceutical company offers a comprehensive range of solutions, including anti-Norfloxacin antibodies and small molecules. These include Carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated molecules. These tools play a crucial role in enabling the sensitive and specific detection of Norfloxacin residues in veterinary samples, ensuring the safety and quality of animal-derived products.
Why Measure Norfloxacin?
Accurate measurement and monitoring of Norfloxacin in veterinary practice are essential for several reasons:
Firstly, it is vital to ensure that animal-derived products comply with regulatory standards. Excessive Norfloxacin residues in food products can pose health risks to consumers. By measuring and monitoring Norfloxacin levels, regulatory authorities can enforce standards that protect the public from potentially harmful residues.
Secondly, antibiotic resistance is a growing concern in both veterinary and human medicine. Norfloxacin, like many antibiotics, has the potential to contribute to the development and spread of antibiotic resistance. By closely monitoring and limiting the use of Norfloxacin in animal husbandry and healthcare, we can help mitigate this risk.
Thirdly, precise measurement of Norfloxacin levels is crucial for optimizing dosage regimens in animals. It ensures that animals receive the right amount of medication to effectively treat infections while minimizing the risk of adverse reactions or the development of resistance. This benefits animal health and welfare.
Our specialized anti-Norfloxacin antibodies and small molecules are invaluable tools in achieving these goals. They enable veterinarians and regulatory authorities to implement robust surveillance strategies to uphold food safety, public health, and sustainable veterinary practices.
Benefits of Using Anti-Norfloxacin Antibodies and Small Molecules
The use of anti-Norfloxacin antibodies and small molecules offers several advantages in veterinary practice and food safety:
High Sensitivity and Specificity: Anti-Norfloxacin antibodies and small molecules are designed to detect Norfloxacin residues with high sensitivity and specificity. This means that even trace amounts of the antibiotic can be identified in veterinary samples, ensuring rigorous monitoring and compliance with regulatory limits.
Early Detection: Early detection of Norfloxacin residues is crucial to prevent contaminated animal-derived products from reaching consumers. Timely intervention can safeguard public health and reduce the economic impact of product recalls.
Versatility: Our range of Norfloxacin-specific molecules includes various formats, such as Carrier-coupled antigens, immunogens, hapten-carrier conjugates, BSA-conjugated, and OVA-conjugated molecules. This versatility allows for a wide range of applications and detection methods, making it easier for laboratories and veterinary professionals to adopt these tools.
Compliance with Regulations: Many countries have stringent regulations in place to limit antibiotic residues in food products. Utilizing anti-Norfloxacin antibodies and small molecules ensures compliance with these regulations and helps avoid legal and reputational issues.
Protection of Animal Health: Accurate measurement of Norfloxacin levels in animals ensures that treatments are effective while minimizing the risk of adverse effects. This safeguards animal health and welfare, a key concern in veterinary medicine.
The Importance of Antibiotic Stewardship in Veterinary Medicine
In recent years, there has been a growing awareness of the need for responsible antibiotic use in veterinary medicine. Antibiotic stewardship is a critical concept that emphasizes the judicious use of antibiotics to preserve their effectiveness and minimize the development of antibiotic-resistant bacteria. Norfloxacin is no exception to this principle.
By measuring and monitoring Norfloxacin levels in animals, veterinarians can play a crucial role in antibiotic stewardship. They can ensure that Norfloxacin is only used when necessary and that appropriate dosages are administered. This approach not only reduces the risk of antibiotic resistance but also minimizes the potential for adverse effects in animals.
Furthermore, the use of anti-Norfloxacin antibodies and small molecules supports the goals of antibiotic stewardship by enabling precise and sensitive detection. This allows for targeted interventions when Norfloxacin is detected, preventing its overuse and the potential for residues in animal-derived products.
Future Directions in Monitoring Norfloxacin
As the field of veterinary medicine and food safety continues to evolve, so do the methods and tools for monitoring Norfloxacin and other antibiotics. Researchers and biopharmaceutical companies are continually working to develop more advanced and efficient detection methods to address emerging challenges.
One promising avenue of research involves the development of rapid diagnostic tests for Norfloxacin residues. These tests can provide quick and on-site detection, allowing for immediate action in cases of contamination. Such advancements can enhance food safety and public health protection.
Additionally, there is a growing focus on the development of digital and data-driven tools for monitoring antibiotic use and residues in veterinary practice. These tools can provide real-time data and insights, facilitating proactive management of antibiotic usage and the detection of residues.
In conclusion, Norfloxacin is a valuable antibiotic in veterinary medicine, but its use and potential for residues in animal-derived products require careful monitoring. The use of anti-Norfloxacin antibodies and small molecules plays a pivotal role in ensuring food safety, protecting public health, and promoting responsible antibiotic use in animals. By staying at the forefront of research and technology, veterinarians and regulatory authorities can continue to improve monitoring methods and uphold the principles of antibiotic stewardship.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.